Cargando…
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearra...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339314/ https://www.ncbi.nlm.nih.gov/pubmed/30658713 http://dx.doi.org/10.1186/s12967-019-1779-5 |
_version_ | 1783388609925087232 |
---|---|
author | He, Weiling Xu, Di Wang, Zhuo Wu, Hui Xiang, Xianhong Tang, Bing Jiang, Wenting Cui, Yongmei Wang, Han Jiang, Neng Sun, Yu Chen, Yangshan Li, Shuhua Hou, Minzhi Zhang, Yang Wang, Liantang Ke, Zun-fu |
author_facet | He, Weiling Xu, Di Wang, Zhuo Wu, Hui Xiang, Xianhong Tang, Bing Jiang, Wenting Cui, Yongmei Wang, Han Jiang, Neng Sun, Yu Chen, Yangshan Li, Shuhua Hou, Minzhi Zhang, Yang Wang, Liantang Ke, Zun-fu |
author_sort | He, Weiling |
collection | PubMed |
description | BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearrangement status was examined through fluorescent in situ hybridization in CTCs enriched by NanoVelcro. RESULTS: NanoVelcro system showed higher CTC-capture efficiency than CellSearch in stage III or IV lung adenocarcinoma. CTC counts obtained by both methods were positively correlated (r = 0.45, p < 0.05). Further, Correlation between CTC counts and pTNM stage determined by NanoVelcro was more significant than that determined by CellSearch (p < 0.001 VS p = 0.029). All ALK-positive patients had 3 or more ALK-rearranged CTC per ml of blood. Less than 3 ALK-rearranged CTC was detected in ALK-negative patients. NanoVelcro can detect the ALK–rearranged status with consistent sensitivity and specificity compared to biopsy test. Furthermore, the ALK-rearranged CTC ratio correlated to the pTNM stage in ALK-positive patients. Following up showed that CTCs counting by NanoVelcro was more stable and reliable in evaluating the efficacy of Clozotinib both in the short and long run compared with CellSearch. Changing of NanoVlecro CTC counts could accurately reflect disease progression. CONCLUSION: NanoVelcro provides a sensitive method for CTC counts and characterization in advanced NSCLC. ALK-rearrangement can be detected in CTCs collected from advanced NSCLC patients by NanoVelcro, facilitating diagnostic test and prognosis analysis, most importantly offering one noninvasive method for real-time monitoring of treatment reaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1779-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6339314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63393142019-01-23 Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma He, Weiling Xu, Di Wang, Zhuo Wu, Hui Xiang, Xianhong Tang, Bing Jiang, Wenting Cui, Yongmei Wang, Han Jiang, Neng Sun, Yu Chen, Yangshan Li, Shuhua Hou, Minzhi Zhang, Yang Wang, Liantang Ke, Zun-fu J Transl Med Research BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearrangement status was examined through fluorescent in situ hybridization in CTCs enriched by NanoVelcro. RESULTS: NanoVelcro system showed higher CTC-capture efficiency than CellSearch in stage III or IV lung adenocarcinoma. CTC counts obtained by both methods were positively correlated (r = 0.45, p < 0.05). Further, Correlation between CTC counts and pTNM stage determined by NanoVelcro was more significant than that determined by CellSearch (p < 0.001 VS p = 0.029). All ALK-positive patients had 3 or more ALK-rearranged CTC per ml of blood. Less than 3 ALK-rearranged CTC was detected in ALK-negative patients. NanoVelcro can detect the ALK–rearranged status with consistent sensitivity and specificity compared to biopsy test. Furthermore, the ALK-rearranged CTC ratio correlated to the pTNM stage in ALK-positive patients. Following up showed that CTCs counting by NanoVelcro was more stable and reliable in evaluating the efficacy of Clozotinib both in the short and long run compared with CellSearch. Changing of NanoVlecro CTC counts could accurately reflect disease progression. CONCLUSION: NanoVelcro provides a sensitive method for CTC counts and characterization in advanced NSCLC. ALK-rearrangement can be detected in CTCs collected from advanced NSCLC patients by NanoVelcro, facilitating diagnostic test and prognosis analysis, most importantly offering one noninvasive method for real-time monitoring of treatment reaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1779-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-18 /pmc/articles/PMC6339314/ /pubmed/30658713 http://dx.doi.org/10.1186/s12967-019-1779-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research He, Weiling Xu, Di Wang, Zhuo Wu, Hui Xiang, Xianhong Tang, Bing Jiang, Wenting Cui, Yongmei Wang, Han Jiang, Neng Sun, Yu Chen, Yangshan Li, Shuhua Hou, Minzhi Zhang, Yang Wang, Liantang Ke, Zun-fu Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title | Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title_full | Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title_fullStr | Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title_full_unstemmed | Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title_short | Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma |
title_sort | three-dimensional nanostructured substrates enable dynamic detection of alk-rearrangement in circulating tumor cells from treatment-naive patients with stage iii/iv lung adenocarcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339314/ https://www.ncbi.nlm.nih.gov/pubmed/30658713 http://dx.doi.org/10.1186/s12967-019-1779-5 |
work_keys_str_mv | AT heweiling threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT xudi threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT wangzhuo threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT wuhui threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT xiangxianhong threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT tangbing threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT jiangwenting threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT cuiyongmei threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT wanghan threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT jiangneng threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT sunyu threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT chenyangshan threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT lishuhua threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT houminzhi threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT zhangyang threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT wangliantang threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma AT kezunfu threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma |